Search Results for "Top 10 Neuroscience Projects To Watch 2013 14"

10:13 EDT 2nd September 2014 | BioPortfolio

Matching Channels

Mesenchymal Epithelial Transition factor c MET

The c-MET signalling pathway consists of the mesenchymal epithelial transition factor (c-MET) transmembrane tyrosine kinase receptor and its ligand hepatocyte growth factor (HGF) or scatter factor (SF...

AstraZeneca

AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and em...

Staphylococcal aureus infections

Staphylococcal aureus infections represent an enormous burden to public health systems. Traditionally restricted to the hospital setting as nosocomial infections, highly virulent strains have recently...

Merck and Co

Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the ...

Lilly

Eli Lilly and Company was founded in 1876, and is now the 9th largest pharmaceutical company based an annual sales which were just under $20bn in 2009. Orginally from the USA, Lilly now operates in ...

Matching News

AT&T Among First To Offer LG G Watch

DALLAS, June 25, 2014 /PRNewswire/ --AT&T today announced it will be among the first U.S. carriers to bring the LG G Watch to its portfolio of accessories. "The LG G Watch is a great addition to A...

There’s no longer anything novel about fitness watches — but at least Withings’ looks good

Withings describes its new Activité watch like this: “The first Swiss made watch that happens to be an activity tracker.” And that’s the coolest thing about this watch. There’s no...

20 Promising Drugs to Watch in 2014

Peter Robins writes for Outsourced Pharma on promising drugs changing clinical phase or receiving approval. Numerous drug therapies changed clinical phase, received approval, and launched in the final...

Fattah Statement on NSF Awarding $10.8 Million in EAGER Grants for Neuroscience Research

WASHINGTON, Aug. 19, 2014 /PRNewswire-USNewswire/ -- Congressman Chaka Fattah (D-PA), lead Democrat appropriator for National Science Foundation (NSF) funding and creator of the Fattah Neuroscience In...

Neurobiologist Thomas Jessell to be honored with 2014 Gruber Neuroscience Prize

Thomas Jessell, PhD, the Claire Tow Professor of Motor Neuron Disorders in the Departments of Neuroscience and of Biochemistry and Molecular Biophysics at Columbia University, is the recipient of the ...

PwC's Q1 IPO Watch Finds IPOs Continue to Dominate the Capital Markets as Activity More than Doubles Compared to Q1 2013

NEW YORK, April 2, 2014 /PRNewswire/ -- The robust market for initial public offerings (IPOs) continued in the first quarter of 2014, and momentum is expected to remain strong into the second quarter...

Considering How Neuroscience Could Influence Moral Decisions

(Bioethics.gov) -  Resuming its consideration of ethical issues generated by neuroscience research, the Presidential Commission for the Study of Bioethical Issues (Bioethics Commission) turned its at...

Neurobiologist Thomas Jessell to receive $500,000 Gruber Neuroscience Prize

(Yale University) Thomas Jessell, Ph.D., the Claire Tow Professor of Motor Neuron Disorders in the Departments of Neuroscience and of Biochemistry and Molecular Biophysics at Columbia University, is t...

Matching PubMed Articles

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement